Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...

Pfizer’s respiratory syncytial virus vaccine was more than 90% effective among older adults during the first season it was available, including among those with underlying conditions or severe disease ...

Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the ...

He acknowledged there is no science backing the connection, but wants researchers to study aluminium adjuvants in childhood ...

Officials say over 1,900 elderly residents have already received the Pfizer shot, and 3,500 more will be inoculated soon.

Pfizer CEO says RFK Jr.'s appointment was not up to him, though he has found common ground with the vaccine skeptic.

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...

The respiratory syncytial virus vaccine is effective in reducing emergency visits, hospitalizations, and severe illness in ...

Pfizer CEO Albert Bourla told Yahoo Finance that Pfizer has a "right to win" on the obesity drugs that have become a major ...

The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...

Move marks shift after years of mRNA collaboration that produced COVID-19 vaccine.